These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3957488)

  • 1. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions of digoxin with nifedipine and diltiazem].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):467-9. PubMed ID: 2277790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of propafenone on the pharmacokinetics of digoxin administered orally: a study in healthy volunteers].
    Cardaioli P; Compostella L; De Domenico R; Papalia D; Zeppellini R; Libardoni M; Pulido E; Cucchini F
    G Ital Cardiol; 1986 Mar; 16(3):237-40. PubMed ID: 3732716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-interaction between nifedipine and digoxin.
    Pedersen KE; Madsen JL; Klitgaard NA; Kjoer K; Hvidt S
    Dan Med Bull; 1986 Apr; 33(2):109-10. PubMed ID: 3709238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
    Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
    Ding R; Tayrouz Y; Riedel KD; Burhenne J; Weiss J; Mikus G; Haefeli WE
    Clin Pharmacol Ther; 2004 Jul; 76(1):73-84. PubMed ID: 15229466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose kinetics of digoxin in neonates.
    Collins-Nakai RL; Schiff D; Ng PK
    Pediatr Pharmacol (New York); 1985; 5(2):117-22. PubMed ID: 4047750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of amiodarone on oral digoxin bioavailability in healthy volunteers.
    Maragno I; Santostasi G; Gaion RM; Paleari C
    Int J Clin Pharmacol Res; 1984; 4(2):149-53. PubMed ID: 6469441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic basis of nifedipine-digoxin interaction: a commentary.
    Kokwaro GO
    East Afr Med J; 1995 Oct; 72(10):684-7. PubMed ID: 8904054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study.
    Boje KM; Dolce JA; Fung HL
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):219-26. PubMed ID: 6515116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
    Ravis WR; Pedersoli WM; Turco JD
    Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variations in the pharmacokinetics, tissue distribution and urinary excretion of nifedipine after a single oral administration to rats.
    Cao QR; Kim TW; Choi JS; Lee BJ
    Biopharm Drug Dispos; 2005 Dec; 26(9):427-37. PubMed ID: 16217814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.